Tzu-Kang Sang

Tzu-Kang Sang


Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2002 in Neuron
Verified
Journal Article
Closed access
GJGeorge R Jackson
George R Jackson
MWMartina Wiedau-Pazos
Martina Wiedau-Pazos
TSTzu-Kang Sang
Tzu-Kang Sang
NWNaveed Wagle
Naveed Wagle
CBCarlos A Brown
Carlos A Brown
DGDaniel H Geschwind
Daniel H Geschwind

Verified
Journal Article
Open access
PDF file
HCHao Chi
Hao Chi
HCHui-Yun Chang
Hui-Yun Chang
TSTzu-Kang Sang
Tzu-Kang Sang
Neuronal cell death in the central nervous system has always been a challenging process to decipher. In normal physiological conditions, neuronal cell death is restricted in the adult brain, even in aged individuals. However, in the pathological conditions of various neurodegenerative diseases, cell death and shrinkage in a specific region of the brain represent a fundamental pathological feature across different neurodegenerative diseases. In this review, we will briefly go through the general pathways of cell death and describe evidence for cell death in the context of individual common neurodegenerative diseases, discussing our current understanding of cell death by connecting with renowned pathogenic proteins, including Tau, amyloid-beta, alpha-synuclein, huntingtin and TDP-43.

17 October 2008 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
SCShreyasi Chatterjee
Shreyasi Chatterjee
TSTzu-Kang Sang
Tzu-Kang Sang
GLGeorge M. Lawless
George M. Lawless
GJGeorge R. Jackson
George R. Jackson
Hyperphosphorylation of tau at multiple sites has been implicated in the formation of neurofibrillary tangles in Alzheimer’s disease; however, the relationship between toxicity and phosphorylation of tau has not been clearly elucidated. Putative tau kinases that play a role in such phosphorylation events include the proline-directed kinases glycogen synthase kinase-3β (GSK-3β) and cyclin-dependent kinase 5 (Cdk5), as well as nonproline-directed kinases such as microtubule affinity-regulating kinase (MARK)/PAR-1; however, whether the cascade of events linking tau phosphorylation and neurodegeneration involves sequential action of kinases as opposed to parallel pathways is still a matter of controversy. Here, we employed a well-characterized Drosophila model of tauopathy to investigate the interdependence of tau kinases in regulating the phosphorylation and toxicity of tau in vivo. We found that tau mutants resistant to phosphorylation by MARK/PAR-1 were indeed less toxic than wild-type tau; however, this was not due to their resistance to phosphorylation by GSK-3β/Shaggy. On the contrary, a tau mutant resistant to phosphorylation by GSK-3β/Shaggy retained substantial toxicity and was found to have increased affinity for microtubules compared with wild-type tau. The fly homologs of Cdk5/p35 did not have major effects on tau toxicity or phosphorylation in this model. These data suggest that, in addition to tau phosphorylation, microtubule binding plays a crucial role in the regulation of tau toxicity when misexpressed. These data have important implications for the understanding and interpretation of animal models of tauopathy.

1 September 2006 in Neuron
Verified
Journal Article
Closed access
SKStanislav L. Karsten
Stanislav L. Karsten
TSTzu-Kang Sang
Tzu-Kang Sang
LGLauren T. Gehman
Lauren T. Gehman
SCShreyasi Chatterjee
Shreyasi Chatterjee
JLJiankai Liu
Jiankai Liu
GJGeorge R. Jackson
George R. Jackson

31 January 2007 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
TSTzu-Kang Sang
Tzu-Kang Sang
HCHui-Yun Chang
Hui-Yun Chang
GLGeorge M. Lawless
George M. Lawless
ARAnuradha Ratnaparkhi
Anuradha Ratnaparkhi
LMLisa Mee
Lisa Mee
GJGeorge R. Jackson
George R. Jackson
Mutations in human parkin have been identified in familial Parkinson's disease and in some sporadic cases. Here, we report that expression of mutant but not wild-type human parkin inDrosophilacauses age-dependent, selective degeneration of dopaminergic (DA) neurons accompanied by a progressive motor impairment. Overexpression or knockdown of theDrosophilavesicular monoamine transporter, which regulates cytosolic DA homeostasis, partially rescues or exacerbates, respectively, the degenerative phenotypes caused by mutant human parkin. These results support a model in which the vulnerability of DA neurons to parkin-induced neurotoxicity results from the interaction of mutant parkin with cytoplasmic dopamine.

3 February 2011 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
YCYa-Chu Chang
Ya-Chu Chang
WHWan-Tzu Hung
Wan-Tzu Hung
YCYun-Chin Chang
Yun-Chin Chang
HCHenry C. Chang
Henry C. Chang
CWChia-Lin Wu
Chia-Lin Wu
TSTzu-Kang Sang
Tzu-Kang Sang
Inclusion body myopathy with Paget's disease of bone and frontotemporal dementia (IBMPFD) is caused by mutations in Valosin-containing protein (VCP), a hexameric AAA ATPase that participates in a variety of cellular processes such as protein degradation, organelle biogenesis, and cell-cycle regulation. To understand how VCP mutations cause IBMPFD, we have established a Drosophila model by overexpressing TER94 (the sole Drosophila VCP ortholog) carrying mutations analogous to those implicated in IBMPFD. Expression of these TER94 mutants in muscle and nervous systems causes tissue degeneration, recapitulating the pathogenic phenotypes in IBMPFD patients. TER94-induced neurodegenerative defects are enhanced by elevated expression of wild-type TER94, suggesting that the pathogenic alleles are dominant active mutations. This conclusion is further supported by the observation that TER94-induced neurodegenerative defects require the formation of hexamer complex, a prerequisite for a functional AAA ATPase. Surprisingly, while disruptions of the ubiquitin-proteasome system (UPS) and the ER–associated degradation (ERAD) have been implicated as causes for VCP–induced tissue degeneration, these processes are not significantly affected in our fly model. Instead, the neurodegenerative defect of TER94 mutants seems sensitive to the level of cellular ATP. We show that increasing cellular ATP by independent mechanisms could suppress the phenotypes of TER94 mutants. Conversely, decreasing cellular ATP would enhance the TER94 mutant phenotypes. Taken together, our analyses have defined the nature of IBMPFD–causing VCP mutations and made an unexpected link between cellular ATP level and IBMPFD pathogenesis. Inclusion body myopathy with Paget's disease of bone and frontotemporal dementia (IBMPFD) is a progressive autosomal dominant disease, characterized by the adult onset of muscle degeneration, abnormal bone metabolism, and drastic behavior changes. IBMPFD is caused by specific mutations in the highly conserved VCP gene, an ATPase known to participate in numerous cellular functions. Because of its diverse functions, it has been difficult to decipher how VCP mutations cause this debilitating disorder. To understand how these specific mutations in VCP lead to IBMPFD, we have developed a Drosophila IBMPFD model by introducing analogous mutations in TER94, the fly VCP homolog. We show that TER94 carrying these specific mutations can disrupt the fly muscle and nervous systems, similar to the symptoms of IBMPFD in humans. These phenotypic similarities suggest that information gained from our analysis of TER94 will enhance our understanding of how VCP mutations cause IBMPFD. By subjecting our fly IBMPFD model to various physiological and genetic manipulations, we have uncovered a novel link between the disease progression and cellular ATP level. Thus, in addition to establishing a fly model for further analysis of this disease, our finding should suggest new therapeutic strategies for IBMPFD.